SIBN

SI-BONE, Inc.

NasdaqAdd to watchlist

Healthcare · Medical Devices

$19.21

+$0.01+0.05%

Delayed · 2026-08-28T20:00:00.000Z · marketstack

16 of 45 open-market sales on file ran under a pre-arranged trading plan ($6.23M), 29 did not. Who, and when

Aug 24, 2026$19.21

−$0.26−1.34%over 1M

Session

Day range15% of range

$19.14$19.61

Fundamentals

Visualize fundamentals and more

Market cap: 854.41M
P/E ratio: -

Revenue grew +20.19% in FY2025, +11.32% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 55
dropped: 61
re-drafted: 58

Out of 298 passages in this year’s Item 1A.

New this year

We believe that our primary competitors marketing implantable devices currently are Alphatec Holding Inc., Aurora Spine Corporation, Globus Medical, Inc., Medtronic plc., and Tenon Medical, Inc. At any time, these or other industry participants may develop …

115 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Data privacy
Reimbursement
Product recalls
Litigation
Debt covenants
AI and its regulation
Cybersecurity

And 19 more.

FDA approval
The 510(k) clearance process of the FDA requires us to document that our product is “substantially equivalent” to another 510(k)-cleared product. The 510(k) process is shorter and typically requires the submission of less supporting documentation than other …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Sep 11 Material agreement Company filing 8-K
Aug 20 FRANCIS LAURA sold 51,884 shares Insider trading Form 4 Chief Executive Officer, about $1.0M, planned (10b5-1)
Aug 4 Quarterly report Company filing 10-Q

15 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 11, 2026 · the newest SEC filing on file

SI-BONE, Inc. investor relations

What SIBN has filed with the SEC. This is not SI-BONE, Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like SI-BONE, Inc.

Also filed under Medical Devices, ranked by how closely they sit beside SIBN.

BSXBoston Scientific Corp.compare with SIBN
MDTMedtronic plccompare with SIBN
ABTAbbott Laboratories

EWEdwards Lifesciences Corpcompare with SIBN

Ask about SI-BONE, Inc.

The assistant answers from what SIBN has actually filed: 9 annual reports filed with the SEC, 128 Form 4 filings from the last year and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from SIBN's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of SI-BONE, Inc. each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with SI-BONE, Inc.

Be told the moment a SIBN insider trades
Put SI-BONE, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
SI-BONE, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about SI-BONE, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Recent activity

Sep 11 Material agreement Company filing 8-K
Aug 20 FRANCIS LAURA sold 51,884 shares Insider trading Form 4 Chief Executive Officer, about $1.0M, planned (10b5-1)
Aug 4 Quarterly report Company filing 10-Q

15 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Data privacy
Reimbursement
Product recalls
Litigation
Debt covenants
AI and its regulation
Cybersecurity

And 19 more.

FDA approval
The 510(k) clearance process of the FDA requires us to document that our product is “substantially equivalent” to another 510(k)-cleared product. The 510(k) process is shorter and typically requires the submission of less supporting documentation than other …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 55
dropped: 61
re-drafted: 58

Out of 298 passages in this year’s Item 1A.

New this year

We believe that our primary competitors marketing implantable devices currently are Alphatec Holding Inc., Aurora Spine Corporation, Globus Medical, Inc., Medtronic plc., and Tenon Medical, Inc. At any time, these or other industry participants may develop …

115 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add